Rash-associated severe neutropenia as a side-effect of indinavir in HIV postexposure prophylaxis [3]

AIDS

Volumn 16, Issue 15, 2002, Pages 2098-2099

  Albrecht, Dirk ^a   Vieler, Tom ^a   Horst, Heinz A ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; DESOGESTREL; ETHINYLESTRADIOL; HORMONE; INDINAVIR; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; ZIDOVUDINE;

ADULT; BLOOD TOXICITY; CASE REPORT; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS COMPLICATION; LETTER; NAUSEA; NEEDLESTICK INJURY; NEUTROPENIA; PRIORITY JOURNAL; PRURITUS; RASH; RESIDENT; SIDE EFFECT; SURGEON;

EID: 0037131413     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200210180-00023     Document Type: Letter

References (3)

1. Brodt HR. Postexposure prophylaxis after HIV exposure. German-Austrian recommendations [in German]. Dtsch Med Wochenschr 1998, 123 (25-26 Suppl.):S2-S16.
2. Gajewski LK, Grimone AJ, Melbourne KM, Vanscoy GJ. Characterization of rash with indinavir in a national patient cohort. Ann Pharmacother 1999, 33:17-21.
3. Schmitz SH, Scheding S, Voliotis D, Rasokat H, Diehl V, Schrappe M. Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood. Ann Hematol 1994, 69:135-138.